{
    "clinical_study": {
        "@rank": "158128", 
        "acronym": "DIANA", 
        "arm_group": {
            "arm_group_label": "patients with major depression", 
            "description": "Inpatients and outpatients diagnosed with an episode of major depression relating to RDD (ICD-10, Version 2010) during the period from January 1, 2012 till September 30, 2013. Initially treated with antidepressant monotherapy, using a flexible dosage regimen if required, for at least 2 week"
        }, 
        "brief_summary": {
            "textblock": "This Non-Interventional Study (NIS) is intended to evaluate the duration of treatment with\n      an initial antidepressant taken as monotherapy in patients in whom treatment was changed\n      because of suboptimal response at physician's discretion. This will address unmet medical\n      needs of patients with a depressive episode related to RDD (ICD-10, Version 2010), who have\n      failed to respond adequately to initial treatment with an antidepressant and contribute to\n      an understanding of the usual approaches that physicians adopt to monitor initial treatment\n      efficacy in RDD (Recurrent Depressive Disorder). The study will also focus on second-line\n      therapy in hard to treat patients, describing the different pharmacotherapeutic strategies."
        }, 
        "brief_title": "Retrospective Observational Study DIANA Study", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Major Depressive Episode", 
        "condition_browse": {
            "mesh_term": [
                "Depressive Disorder", 
                "Depression", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1. Female or male aged between 18 and 65 years Inpatients and outpatients diagnosed with\n        an episode of major depression relating to RDD (ICD-10, Version 2010) during the period\n        from January 1, 2012 till September 30, 2013 3. Initially treated with antidepressant\n        monotherapy, using a flexible dosage regimen if required, for at least 2 weeks 4. Initial\n        treatment changed because of a suboptimal response at physician's discretion, which is\n        clearly documented in the patient's medical chart.\n\n        Exclusion Criteria:\n\n        Patients currently participating in any other clinical or non-interventional trial, or\n        have completed their participation with the last 30 days.\n\n        2. Patients with current psychiatric or general medical conditions which require\n        concomitant use of lithium, thyroid hormones, or atypical antipsychotics 3. Patients with\n        unstable general medical condition. 4. Patients who were pregnant or were suspected to be\n        pregnant during the period when a patient had received treatment for MDE (Major Depressive\n        Episode)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Inpatients and outpatients diagnosed with an episode of major depression relating to RDD\n        (ICD-10, Version 2010) during the period from January 1, 2012 till September 30, 2013.\n        Initially treated with antidepressant monotherapy, using a flexible dosage regimen if\n        required, for at least 2 weeks"
            }
        }, 
        "enrollment": {
            "#text": "450", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976793", 
            "org_study_id": "NIS-NRU-ATC-2013/1"
        }, 
        "intervention_browse": {
            "mesh_term": "Antidepressive Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Recurrent depressive disorder", 
            "Depression", 
            "Depressive episode", 
            "Atypical antipsychotics"
        ], 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Ivanovo", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kazan", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nizhniy Novgorod", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rostov-on-Don", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Petersburg", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stavropol", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Research Site"
                }
            }
        ], 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_groups": "1", 
        "official_title": "Retrospective Observational Study to Estimate the Duration of Initial Antidepressant Treatment in Patients With Recurrent Depressive Disorder Who Demonstrated a Suboptimal Response to Therapy: DIANA Study", 
        "overall_official": [
            {
                "affiliation": "Center of Social and Forensic Psychiatry, Moscow", 
                "last_name": "Alla Avedisova, Prof", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "AstraZeneca Russia", 
                "last_name": "Karin Otter, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Scientific centef of Mental Health, Moscow", 
                "last_name": "Anatoly Smulevich, Prof", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St Petersburg Scientific Psyconeurology institute", 
                "last_name": "Galina Mazo, Prof", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Russia: Independent Interdisciplinary Committee of ethical review of clinical trials", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Primary objective: The primary objective of this NIS is to evaluate the duration of treatment with an initial antidepressant taken as monotherapy in patients in whom treatment was changed because of suboptimal response at physician's discretion.", 
            "measure": "Duration of treatment considered as time between initiation of antidepressant monotherapy and the alteration and/or augmentation of pharmacotherapy", 
            "safety_issue": "No", 
            "time_frame": "up to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976793"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Distribution of the various pharmacotherapy strategies following suboptimal response: (switch; augmentation; combination of switch and augmentation and discontinuation of pharmacotherapy) among the patients population.", 
                "measure": "Pharmacotherapy strategy for the second line treatment", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "description": "Rate of the different pharmacological agents prescribed for augmentation; rout of their administration; mean and median duration of courses of treatment", 
                "measure": "International Non-Proprietary Name (INN) of pharmacological agents prescribed for augmentation", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "Mean and median doses of pharmacological agents used for augmentation", 
                "measure": "Doses of pharmacological agents used for augmentation", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "Distribution of various sources of the patient's referral to a psychiatrist (psychotherapist; neurologist; internist; physician of other speciality; psychologist; came himself; other; and not known", 
                "measure": "Source of the patient's referral to a psychiatrist", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}